Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
Essential Hypertension
Interventions
DRUG

telmisartan plus hydrochlorothiazide

Combination therapy with telmisartan (40 mg/day) plus hydrochlorothiazide (12.5 mg/day): If blood pressure is not reach to lower than 140/90 mmHg, dose of telmisartan can be increased to 80 mg/day

DEVICE

Amlodipine

Trial Locations (1)

113-8655

Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo

All Listed Sponsors
lead

Tokyo University

OTHER

NCT00509470 - Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine | Biotech Hunter | Biotech Hunter